vinay prasad - Search News

News

FDA names Dr. Vinay Prasad

FDA names Dr. Vinay Prasad as top vaccine official

In his new role with the FDA, Dr. Vinay Prasad will oversee the regulation of costly drugs, including vaccines, gene therapies, and blood supply.

CNN International on MSN · 1d

FDA chooses Dr. Vinay Prasad to lead biologics, vaccines division

The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics Evaluation and Research, the division that oversees vaccines and biologic medicines.

MedPage Today on MSN · 2d

Vinay Prasad, Critic of COVID Measures, Picked as FDA's Top Vaccine Official

Vinay Prasad, MD, MPH, a frequent critic of the FDA and COVID-19 lockdowns and vaccination policies, will be the next director of FDA's Center for Biologics Evaluation and Research (CBER), the center that oversees vaccine approvals.

Axios on MSN2h

Vinay Prasad believes that the FDA too often has acted as a rubber stamp for pharma, both big and small.

Biotech venture capital is risky business, inherently at the mercy of regulators and binary outcomes. Now it may face a new ...

New CBER Director Vinay Prasad praises evidence, FDA reviewers in first speech to staff

WASHINGTON — In his first address to FDA staff on Wednesday, Vinay Prasad emphasized his commitment to evidence, his ...

BioPharma Dive2h

Biotech is guessing how Vinay Prasad might change the FDA. His research, writing offer clues.

CBER’s new chief has argued for more stringent measures of assessing drugs for cancer and rare diseases, suggesting he might ...

23hon MSN

The FDA names a new vaccine chief with an unsettling record, joining a controversial team

Dr. Vinay Prasad, the FDA's new vaccine chief, has been accused of spreading misinformation about Covid vaccines.

Vinay Prasad, in his own words, outlines the philosophy he’ll bring to the FDA

Not Vinay Prasad. The new top regulator of vaccines and gene therapies at the Food and Drug Administration has never shied ...

The American Journal of Managed Care19h

Biotech Stocks Slide After FDA Selects Prasad to Lead CBER

The FDA's decision to appoint Vinay Prasad, MD, MPH, to head its Center for Biologics Evaluation and Research (CBER) raised ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results